Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?

BACKGROUND: Our objective is to estimate the effects associated with higher rates of renin‐angiotensin system antagonists, angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARBs), in secondary prevention for geriatric (aged >65 years) patients with new ischemic stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, John M., Chapman, Cole G., Suneja, Manish, Schroeder, Mary C., Fravel, Michelle A., Schneider, Kathleen M., Wilwert, June, Li, Yi‐Jhen, Chrischilles, Elizabeth A., Brenton, Douglas W., Brenton, Marian, Robinson, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015383/
https://www.ncbi.nlm.nih.gov/pubmed/29848495
http://dx.doi.org/10.1161/JAHA.118.009137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015383/
https://www.ncbi.nlm.nih.gov/pubmed/29848495
http://dx.doi.org/10.1161/JAHA.118.009137

Ejemplares similares